Combination of erythropoietin and sildenafil can effectively attenuate hypoxia-induced pulmonary hypertension in mice.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4070833)

Published in Pulm Circ on December 01, 2013

Authors

Victor Samillan1, Thomas Haider2, Johannes Vogel2, Caroline Leuenberger3, Matthias Brock4, Colin Schwarzwald5, Max Gassmann6, Louise Ostergaard2

Author Affiliations

1: Institute for Veterinary Physiology, Vetsuisse Faculty, Zurich, Switzerland ; Zurich Center for Integrative Human Physiology, Zurich, Switzerland ; Human Physiology Department, Medical School, Universidad Alas Peruanas, Lima, Peru.
2: Institute for Veterinary Physiology, Vetsuisse Faculty, Zurich, Switzerland ; Zurich Center for Integrative Human Physiology, Zurich, Switzerland.
3: Institute for Veterinary Physiology, Vetsuisse Faculty, Zurich, Switzerland ; Institute of Human Movement Sciences and Sport, ETH Zurich, Zurich, Switzerland.
4: Institute for Veterinary Physiology, Vetsuisse Faculty, Zurich, Switzerland ; Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
5: Equine Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
6: Institute for Veterinary Physiology, Vetsuisse Faculty, Zurich, Switzerland ; Zurich Center for Integrative Human Physiology, Zurich, Switzerland ; Universidad Peruana Cayetano Heredia, Lima, Peru.

Articles cited by this

Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med (2005) 9.27

Oxygen sensing, homeostasis, and disease. N Engl J Med (2011) 5.03

Pathophysiology of sleep apnea. Physiol Rev (2010) 4.69

Erythropoietin: structure, control of production, and function. Physiol Rev (1992) 4.24

Atrial natriuretic factor: a hormone produced by the heart. Science (1985) 3.07

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med (2002) 2.69

Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol (2011) 2.39

Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A (1995) 2.11

Lactic acidosis update for critical care clinicians. J Am Soc Nephrol (2001) 1.78

Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation (2006) 1.53

Altered pulmonary vascular reactivity in mice with excessive erythrocytosis. Am J Respir Crit Care Med (2003) 1.48

Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis (2011) 1.47

Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. J Physiol (2011) 1.46

Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension (2001) 1.35

A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am J Physiol Lung Cell Mol Physiol (2012) 1.18

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med (2004) 1.13

Effects of recombinant human erythropoietin in normal humans. J Physiol (2010) 1.12

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Adv Ther (2009) 1.10

Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol (2011) 1.08

Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr Opin Clin Nutr Metab Care (2004) 1.08

Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies. J Physiol (2005) 1.00

cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue. Am J Pathol (2002) 0.99

Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension. Am J Cardiol (2011) 0.97

Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS One (2011) 0.97

Current therapeutics and practical management strategies for pulmonary arterial hypertension. Am Heart J (2011) 0.96

Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis (2004) 0.92

Pulmonary arterial hypertension. Curr Probl Cardiol (2011) 0.91

Isoflurane-induced acidosis depresses basal and PGE(2)-stimulated duodenal bicarbonate secretion in mice. Am J Physiol Gastrointest Liver Physiol (2006) 0.90

Breathing at high altitude. Cell Mol Life Sci (2009) 0.89

Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Thromb Haemost (2005) 0.88

The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use. Med Res Rev (2012) 0.87

Nitric oxide-dependent pulmonary vasodilation in polycythemic rats. Am J Physiol Heart Circ Physiol (2000) 0.84

Cardiopulmonary interaction in heart failure. Pulm Pharmacol Ther (2006) 0.81

Effects of erythropoietin on advanced pulmonary vascular remodelling. Eur Respir J (2007) 0.80

Erythropoietin. J Endocrinol Invest (2003) 0.78

Ventilatory response to acute hypoxia in transgenic mice over-expressing erythropoietin: effect of acclimation to 3-week hypobaric hypoxia. Respir Physiol Neurobiol (2007) 0.78

Erythropoietin induces positive inotropic and lusitropic effects in murine and human myocardium. J Mol Cell Cardiol (2011) 0.77

Erythropoietin, but not asialoerythropoietin or carbamyl-erythropoietin, attenuates monocrotaline-induced pulmonary hypertension in rats. Clin Exp Hypertens (2012) 0.77

Exogenous erythropoietin fails to augment hypoxic pulmonary hypertension in rats. Respir Physiol (1993) 0.77

Erythropoietin. Compr Physiol (2011) 0.77

Using plethysmography to determine erythropoietin's impact on neural control of ventilation. Methods Mol Biol (2013) 0.76